Upjohn buys Scherer ophthalmic drug delivery system :
This article was originally published in Clinica
RP Scherer is to sell its patented ophthalmic drug delivery system to Pharmacia & Upjohn for an undisclosed amount. The pocket-sized device delivers a fine spray of liquid therapies and claims to be more effectiveness and convenient for the patient.
You may also be interested in...
Abbott is launching a second test to detect COVID-19. The diagnostics giant announced on 27 March the release of a rapid, point-of-care test that can deliver results within five minutes.
President Trump on 27 March finally pulled the trigger on using his powers under the Defense Production Act, forcing General Motors Co. to manufacture medical ventilators. The only thing is, GM is already doing that.
Theradaptive's “paint-like” regenerative therapeutic can be applied to any device to promote bone regrowth or regenerate tissue.